BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut. 2001;49:268-275. [PMID: 11454805 DOI: 10.1136/gut.49.2.268] [Cited by in Crossref: 171] [Cited by in F6Publishing: 145] [Article Influence: 8.1] [Reference Citation Analysis]
Number Citing Articles
1 Ruiz-del-Árbol L, Serradilla R. Cirrhotic cardiomyopathy. World J Gastroenterol 2015; 21(41): 11502-11521 [PMID: 26556983 DOI: 10.3748/wjg.v21.i41.11502] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 55] [Article Influence: 11.1] [Reference Citation Analysis]
2 Rahman S, Mallett SV. Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients. World J Hepatol 2015; 7(3): 507-520 [PMID: 25848474 DOI: 10.4254/wjh.v7.i3.507] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
3 Koshy AN, Farouque O, Calafiore P, Gow PJ. Letter to the Editor: Diagnosis of Cirrhotic Cardiomyopathy: The Role of an Impaired Cardiac Reserve. Hepatology 2020;71:1883-1883. [DOI: 10.1002/hep.31034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 2009;104:2458-2466. [PMID: 19532126 DOI: 10.1038/ajg.2009.321] [Cited by in Crossref: 119] [Cited by in F6Publishing: 92] [Article Influence: 9.2] [Reference Citation Analysis]
5 Al Hamoudi W, Lee SS. Cirrhotic Cardiomyopathy. Annals of Hepatology 2006;5:132-9. [DOI: 10.1016/s1665-2681(19)31996-9] [Cited by in Crossref: 25] [Article Influence: 1.6] [Reference Citation Analysis]
6 Sampaio F, Lamata P, Bettencourt N, Alt SC, Ferreira N, Kowallick JT, Pimenta J, Kutty S, Fraga J, Steinmetz M. Assessment of cardiovascular physiology using dobutamine stress cardiovascular magnetic resonance reveals impaired contractile reserve in patients with cirrhotic cardiomyopathy. J Cardiovasc Magn Reson. 2015;17:61. [PMID: 26187817 DOI: 10.1186/s12968-015-0157-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol. 2006;44:994-1002. [PMID: 16510203 DOI: 10.1016/j.jhep.2005.10.034] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 6.3] [Reference Citation Analysis]
8 Møller S, Bernardi M. Interactions of the heart and the liver. Eur Heart J 2013;34:2804-11. [PMID: 23853073 DOI: 10.1093/eurheartj/eht246] [Cited by in Crossref: 216] [Cited by in F6Publishing: 167] [Article Influence: 24.0] [Reference Citation Analysis]
9 Muilenburg DJ, Singh A, Torzilli G, Khatri VP. Surgery in the Patient with Liver Disease. Medical Clinics of North America 2009;93:1065-81. [DOI: 10.1016/j.mcna.2009.05.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
10 Wiese S, Liang M, Mo S, Bendtsen F, Hove JD, Møller S. Left atrial volume changes assessed by real time 3-dimensional echocardiography in relation to liver function and prognosis in patients with cirrhosis. Int J Cardiovasc Imaging 2020;36:2121-7. [DOI: 10.1007/s10554-020-01920-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Polavarapu N, Tripathi D. Liver in cardiopulmonary disease. Best Pract Res Clin Gastroenterol. 2013;27:497-512. [PMID: 24090938 DOI: 10.1016/j.bpg.2013.06.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Alexopoulou A, Papatheodoridis G, Pouriki S, Chrysohoou C, Raftopoulos L, Stefanadis C, Pectasides D. Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transpl Int. 2012;25:1174-1181. [PMID: 22909305 DOI: 10.1111/j.1432-2277.2012.01547.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
13 Baysal M, Ortaburun Y, Soylu AR, Yılmaztepe MA, Baysal S, Umit E, Umit H, Tezel A, Muzaffer Demir A. Autonomic and diastolic dysfunction association with quality of life impairment in cirrhotic patients. Arab J Gastroenterol 2020;21:32-6. [PMID: 32088164 DOI: 10.1016/j.ajg.2020.01.003] [Reference Citation Analysis]
14 Wong F, Salerno F. Beta-blockers in cirrhosis: friend and foe? Hepatology. 2010;52:811-813. [PMID: 20812354 DOI: 10.1002/hep.23852] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
15 Alameri HF, Sanai FM, Al Dukhayil M, Azzam NA, Al-Swat KA, Hersi AS, Abdo AA. Six Minute Walk Test to assess functional capacity in chronic liver disease patients. World J Gastroenterol 2007; 13(29): 3996-4001 [PMID: 17663517 DOI: 10.3748/wjg.v13.i29.3996] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
16 Terziyski K, Andonov V, Marinov B, Kostianev S. Exercise performance and ventilatory efficiency in patients with mild and moderate liver cirrhosis. Clin Exp Pharmacol Physiol. 2008;35:135-140. [PMID: 18197891 DOI: 10.1111/j.1440-1681.2007.04751.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
17 Koshy AN, Gow PJ, Testro A, Teh AW, Ko J, Lim HS, Han HC, Weinberg L, VanWagner LB, Farouque O. Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm. Am J Transplant 2021;21:2240-5. [PMID: 33453141 DOI: 10.1111/ajt.16500] [Reference Citation Analysis]
18 Josefsson A, Fu M, Björnsson E, Castedal M, Kalaitzakis E. Impact of cardiac dysfunction on health-related quality of life in cirrhotic liver transplant candidates. Eur J Gastroenterol Hepatol 2015;27:393-8. [PMID: 25874511 DOI: 10.1097/MEG.0000000000000292] [Reference Citation Analysis]
19 de Souza SLB, Mota GAF, Gregolin CS, do Nascimento M, Luvizotto RAM, Bazan SGZ, Sugizaki MM, Barbisan LF, Cicogna AC, do Nascimento AF. Exercise Training Attenuates Cirrhotic Cardiomyopathy. J of Cardiovasc Trans Res 2021;14:674-84. [DOI: 10.1007/s12265-020-09997-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Mira PAC, Falci MFA, Moreira JB, Guerrero RVD, Ribeiro TCDR, Barbosa KVBD, Pace FHL, Martinez DG, Laterza MC. Blunted blood pressure response to exercise and isolated muscle metaboreflex activation in patients with cirrhosis. Appl Physiol Nutr Metab 2021;46:273-9. [PMID: 32941782 DOI: 10.1139/apnm-2020-0407] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Escobar B, Taurá P, Martínez-Palli G, Fondevila C, Balust J, Beltrán J, Fernández J, García-Pagán JC, García-Valdecasas JC. Stroke volume response to liver graft reperfusion stress in cirrhotic patients. World J Surg. 2014;38:927-935. [PMID: 24132825 DOI: 10.1007/s00268-013-2289-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
22 Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathy. Dig Liver Dis. 2007;39:507-515. [PMID: 17383244 DOI: 10.1016/j.dld.2006.12.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
23 Baik SK, Lee SS. Cirrhotic cardiomyopathy: causes and consequences. J Gastroenterol Hepatol 2004;19:S185-90. [DOI: 10.1111/j.1440-1746.2004.03639.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Kadaja L, Kisand KE, Peet N, Braun U, Metsküla K, Teesalu K, Vibo R, Kisand KV, Uibo R, Jockusch H, Seppet EK. IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units? Mol Cell Biochem 2004;256-257:291-303. [PMID: 14977189 DOI: 10.1023/b:mcbi.0000009876.23921.e6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
25 Dahl EK, Møller S, Kjær A, Petersen CL, Bendtsen F, Krag A. Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study. Scand J Gastroenterol 2014;49:362-72. [PMID: 24329122 DOI: 10.3109/00365521.2013.867359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
26 Kazankov K, Holland-Fischer P, Andersen NH, Torp P, Sloth E, Aagaard NK, Vilstrup H. Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int. 2011;31:534-540. [PMID: 21382164 DOI: 10.1111/j.1478-3231.2011.02468.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 7.0] [Reference Citation Analysis]
27 Salerno F, Cazzaniga M, Pagnozzi G, Cirello I, Nicolini A, Meregaglia D, Burdick L. Humoral and cardiac effects of TIPS in cirrhotic patients with different “effective” blood volume. Hepatology. 2003;38:1370-1377. [PMID: 14647047 DOI: 10.1016/j.hep.2003.09.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
28 Zaky A, Bendjelid K. Appraising cardiac dysfunction in liver transplantation: an ongoing challenge. Liver Int. 2015;35:12-29. [PMID: 24797833 DOI: 10.1111/liv.12582] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
29 Ruíz-del-árbol L, Achécar L, Serradilla R, Rodríguez-gandía MÁ, Rivero M, Garrido E, Natcher JJ. Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine. Hepatology 2013;58:1732-41. [DOI: 10.1002/hep.26509] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 9.4] [Reference Citation Analysis]
30 Mechelinck M, Hartmann B, Hamada S, Becker M, Andert A, Ulmer TF, Neumann UP, Wirtz TH, Koch A, Trautwein C, Roehl AB, Rossaint R, Hein M. Global Longitudinal Strain at Rest as an Independent Predictor of Mortality in Liver Transplant Candidates: A Retrospective Clinical Study. J Clin Med 2020;9:E2616. [PMID: 32806645 DOI: 10.3390/jcm9082616] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Puchades L, Chau S, Dodson JA, Mohamad Y, Mustain R, Lebsack A, Aguilera V, Prieto M, Lai JC. Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study. Transplantation 2018;102:e101-7. [PMID: 29189486 DOI: 10.1097/TP.0000000000002025] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Brondex A, Arlès F, Lipovac AS, Richecoeur M, Bronstein JA. [Cirrhotic cardiomyopathy: a specific entity]. Ann Cardiol Angeiol (Paris). 2012;61:99-104. [PMID: 22115174 DOI: 10.1016/j.ancard.2011.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, McPhail MJ, Willars C, Auzinger G, Sizer E, Heneghan M. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014;20:54-62. [PMID: 24136710 DOI: 10.1002/lt.23766] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 6.8] [Reference Citation Analysis]
34 Yotti R, Ripoll C, Benito Y, Catalina MV, Elízaga J, Rincón D, Fernández-avilés F, Bermejo J, Bañares R. Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis. Hepatology 2017;65:2019-30. [DOI: 10.1002/hep.29104] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
35 Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS. Prediction of cardiac complications after liver transplantation. Transplantation. 2009;87:763-770. [PMID: 19295324 DOI: 10.1097/tp.0b013e318198d734] [Cited by in Crossref: 104] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
36 Leithead JA, Hayes PC, Ferguson JW. Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction. Aliment Pharmacol Ther. 2014;39:699-711. [PMID: 24528130 DOI: 10.1111/apt.12653] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
37 Wong F. Cirrhotic cardiomyopathy. Hepatol Int 2009;3:294-304. [PMID: 19669380 DOI: 10.1007/s12072-008-9109-7] [Cited by in Crossref: 114] [Cited by in F6Publishing: 98] [Article Influence: 8.1] [Reference Citation Analysis]
38 Liu H, Jayakumar S, Traboulsi M, Lee SS. Cirrhotic cardiomyopathy: Implications for liver transplantation. Liver Transpl. 2017;23:826-835. [PMID: 28407402 DOI: 10.1002/lt.24768] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 17.0] [Reference Citation Analysis]
39 Kaur H, Premkumar M. Diagnosis and Management of Cirrhotic Cardiomyopathy. Journal of Clinical and Experimental Hepatology 2022;12:186-99. [DOI: 10.1016/j.jceh.2021.08.016] [Reference Citation Analysis]
40 Jang D, Jun I, Moon Y, Shin W, Song J, Hwang G. Pretransplant Left Ventricular Dysfunction Adversely Affects Perioperative Outcomes in Pediatric Liver Transplantation: A Retrospective Observational Study. Transplantation Proceedings 2016;48:3328-35. [DOI: 10.1016/j.transproceed.2016.08.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
41 Kim SY, Kim KH, Schilling JM, Leem J, Dhanani M, Head BP, Roth DM, Zemljic-Harpf AE, Patel HH. Protective role of cardiac-specific overexpression of caveolin-3 in cirrhotic cardiomyopathy. Am J Physiol Gastrointest Liver Physiol 2020;318:G531-41. [PMID: 31961720 DOI: 10.1152/ajpgi.00346.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Edginton AN, Willmann S. Physiology-based simulations of a pathological condition: prediction of pharmacokinetics in patients with liver cirrhosis. Clin Pharmacokinet 2008;47:743-52. [PMID: 18840029 DOI: 10.2165/00003088-200847110-00005] [Cited by in Crossref: 104] [Cited by in F6Publishing: 89] [Article Influence: 8.0] [Reference Citation Analysis]
43 De Marco M, Chinali M, Romano C, Benincasa M, D’Addeo G, D’Agostino L, de Simone G. Increased left ventricular mass in pre-liver transplantation cirrhotic patients. J Cardiovasc Med (Hagerstown). 2008;9:142-146. [PMID: 18192806 DOI: 10.2459/jcm.0b013e3280c7c29c] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
44 Téllez L, Ibáñez-Samaniego L, Pérez Del Villar C, Yotti R, Martínez J, Carrión L, Rodríguez de Santiago E, Rivera M, González-Mansilla A, Pastor Ó, Bermejo J, Bañares R, Albillos A. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites. J Hepatol 2020;73:1404-14. [PMID: 32446716 DOI: 10.1016/j.jhep.2020.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
45 Mira PAC, Henrique DMN, Loschi RQ, Falci MFA, Guerrero RVD, Machado Júnior TB, Barbosa KVBD, Ribeiro TCDR, Pace FHL, Martinez DG, Laterza MC. Cardiac baroreflex function and vascular reactivity recovery after aerobic exercise in patients with early cirrhosis. Blood Press Monit 2020;25:324-31. [PMID: 32701564 DOI: 10.1097/MBP.0000000000000474] [Reference Citation Analysis]
46 Lemyze M, Dharancy S, Nevière R, Wallaert B. Cardiopulmonary response to exercise in patients with liver cirrhosis and impaired pulmonary gas exchange. Respir Med. 2011;105:1550-1556. [PMID: 21764574 DOI: 10.1016/j.rmed.2011.06.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
47 Khemakanok K, Khositseth A, Treepongkaruna S, Teeraratkul S, Pansrimangkorn W, Leelaudomlipi S, Bunmee U, Sriphojanart S. Cardiac abnormalities in cirrhotic children: pre- and post-liver transplantation. Hepatol Int 2016;10:518-24. [DOI: 10.1007/s12072-015-9674-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
48 Møller S, Hove JD, Dixen U, Bendtsen F. New insights into cirrhotic cardiomyopathy. International Journal of Cardiology 2013;167:1101-8. [DOI: 10.1016/j.ijcard.2012.09.089] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 7.2] [Reference Citation Analysis]
49 Zaky A, Lang JD, Treggiari M. Towards a better characterization of cirrhosis-associated cardiomyopathy? J Hepatol. 2013;59:192-193. [PMID: 23415930 DOI: 10.1016/j.jhep.2013.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Josefsson A, Fu M, Allayhari P, Björnsson E, Castedal M, Olausson M, Kalaitzakis E. Impact of peri-transplant heart failure & left-ventricular diastolic dysfunction on outcomes following liver transplantation. Liver Int 2012;32:1262-9. [DOI: 10.1111/j.1478-3231.2012.02818.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
51 Møller S, Bendtsen F. Cirrhotic Multiorgan Syndrome. Dig Dis Sci 2015;60:3209-25. [DOI: 10.1007/s10620-015-3752-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
52 Dimitroglou Y, Aggeli C, Alexopoulou A, Mavrogeni S, Tousoulis D. Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives. J Clin Med 2019;8:E2132. [PMID: 31817014 DOI: 10.3390/jcm8122132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Locklear CT, Golabi P, Gerber L, Younossi ZM. Exercise as an intervention for patients with end-stage liver disease: Systematic review. Medicine (Baltimore). 2018;97:e12774. [PMID: 30334965 DOI: 10.1097/md.0000000000012774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
54 Baibhav B, Mahabir CA, Xie F, Shostrom VK, McCashland TM, Porter TR. Predictive Value of Dobutamine Stress Perfusion Echocardiography in Contemporary End-Stage Liver Disease. J Am Heart Assoc 2017;6:e005102. [PMID: 28219921 DOI: 10.1161/JAHA.116.005102] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
55 Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, Meregaglia D, Nicolini A. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut. 2007;56:869-875. [PMID: 17135305 DOI: 10.1136/gut.2006.102467] [Cited by in Crossref: 144] [Cited by in F6Publishing: 114] [Article Influence: 9.0] [Reference Citation Analysis]
56 Yadav A, Chang YH, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE, Carey EJ. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015;29:134-141. [PMID: 25430554 DOI: 10.1111/ctr.12493] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 10.9] [Reference Citation Analysis]
57 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406-460. [PMID: 29653741 DOI: 10.1016/j.jhep.2018.03.024] [Cited by in Crossref: 660] [Cited by in F6Publishing: 520] [Article Influence: 165.0] [Reference Citation Analysis]
58 Gaskari SA, Honar H, Lee SS. Therapy insight: Cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol 2006;3:329-37. [PMID: 16741552 DOI: 10.1038/ncpgasthep0498] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 5.6] [Reference Citation Analysis]
59 Aamann L, Dam G, Rinnov AR, Vilstrup H, Gluud LL. Physical exercise for people with cirrhosis. Cochrane Database Syst Rev 2018;12:CD012678. [PMID: 30575956 DOI: 10.1002/14651858.CD012678.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
60 Desai MS, Mathur B, Eblimit Z, Vasquez H, Taegtmeyer H, Karpen SJ, Penny DJ, Moore DD, Anakk S. Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology. 2017;65:189-201. [PMID: 27774647 DOI: 10.1002/hep.28890] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
61 Wong F. Cardiac changes in pediatric liver transplant recipients: are they truly irreversible? Hepatol Int 2016;10:390-3. [PMID: 26884376 DOI: 10.1007/s12072-016-9708-7] [Reference Citation Analysis]
62 Aday AW, Mayo MJ, Elliott A, Rockey DC. The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites. Am J Med Sci 2016;351:169-76. [PMID: 26897272 DOI: 10.1016/j.amjms.2015.11.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
63 Shephard RJ, Johnson N. Effects of physical activity upon the liver. Eur J Appl Physiol 2015;115:1-46. [DOI: 10.1007/s00421-014-3031-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
64 Premkumar M, Devurgowda D, Vyas T, Shasthry SM, Khumuckham JS, Goyal R, Thomas SS, Kumar G. Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis. J Clin Exp Hepatol 2019;9:324-33. [PMID: 31360025 DOI: 10.1016/j.jceh.2018.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
65 Møller S, Henriksen JH. Cardiopulmonary complications in chronic liver disease. World J Gastroenterol 2006; 12(4): 526-538 [PMID: 16489664 DOI: 10.3748/wjg.v12.i4.526] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
66 Zhao J, Li S, Ren L, Guo X, Qi X. Pro-Brain Natriuretic Peptide and Troponin T-Hypersensitivity Levels Correlate With the Severity of Liver Dysfunction in Liver Cirrhosis. Am J Med Sci 2017;354:131-9. [PMID: 28864370 DOI: 10.1016/j.amjms.2017.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
67 Mandell MS, Tsou M. Cardiovascular Dysfunction in Patients with End-stage Liver Disease. Journal of the Chinese Medical Association 2008;71:331-5. [DOI: 10.1016/s1726-4901(08)70134-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
68 Mandell MS, Lindenfeld J, Tsou MY, Zimmerman M. Cardiac evaluation of liver transplant candidates. World J Gastroenterol 2008; 14(22): 3445-3451 [PMID: 18567069 DOI: 10.3748/wjg.14.3445] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
69 Møller S, Henriksen JH, Bendtsen F. Extrahepatic complications to cirrhosis and portal hypertension: Haemodynamic and homeostatic aspects. World J Gastroenterol 2014; 20(42): 15499-15517 [PMID: 25400435 DOI: 10.3748/wjg.v20.i42.15499] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
70 Krag A, Bendtsen F, Dahl EK, Kjær A, Petersen CL, Møller S. Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study. PLoS One 2014;9:e109179. [PMID: 25279659 DOI: 10.1371/journal.pone.0109179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
71 Can MG, Özer A, İyigün M, Gökay BV, Emiroğlu R. Takotsubo Cardiomyopathy Resulting in Cardiac Arrest in a Patient Undergoing Liver Transplantation. Transplant Proc 2017;49:2392-4. [PMID: 29198687 DOI: 10.1016/j.transproceed.2017.09.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
72 Ebrahimi F, Tavakoli S, Hajrasouliha AR, Sadeghipour H, Dehghani M, Ahmadi SH, Dehpour AR. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats. Fundam Clin Pharmacol 2006;20:461-71. [PMID: 16968416 DOI: 10.1111/j.1472-8206.2006.00431.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
73 Berardis S, Sattwika PD, Najimi M, Sokal EM. Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects. World J Gastroenterol 2015; 21(3): 742-758 [PMID: 25624709 DOI: 10.3748/wjg.v21.i3.742] [Cited by in CrossRef: 74] [Cited by in F6Publishing: 71] [Article Influence: 10.6] [Reference Citation Analysis]
74 Papastergiou V, Skorda L, Lisgos P, Papakonstantinou N, Giakoumakis T, Ntousikos K, Karatapanis S. Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: is there a correlation between the grade of diastolic dysfunction and the grade of liver disease? ScientificWorldJournal 2012;2012:615057. [PMID: 22888308 DOI: 10.1100/2012/615057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
75 Jones JC, Coombes JS, Macdonald GA. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transpl. 2012;18:146-151. [PMID: 22139897 DOI: 10.1002/lt.22472] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 8.5] [Reference Citation Analysis]
76 Ripoll C, Catalina MV, Yotti R, Olmedilla L, Pérez-Peña J, Lo Iacono O, Rincón D, García-Fernández MA, Bermejo J, Bañares R. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008;85:1766-72. [PMID: 18580469 DOI: 10.1097/TP.0b013e318172c936] [Cited by in Crossref: 60] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
77 Sun F, Wang Y, Wang B, Tong J, Zhang D, Chang B. Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease. Hepatobiliary & Pancreatic Diseases International 2011;10:50-4. [DOI: 10.1016/s1499-3872(11)60007-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
78 Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int 2014;8:308-15. [PMID: 25221635 DOI: 10.1007/s12072-014-9531-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
79 Frye JW, Perri RE. Perioperative risk assessment for patients with cirrhosis and liver disease. Expert Rev Gastroenterol Hepatol. 2009;3:65-75. [PMID: 19210114 DOI: 10.1586/17474124.3.1.65] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
80 Lee SS, Liu H. Cardiovascular determinants of survival in cirrhosis. Gut. 2007;56:746-748. [PMID: 17519479 DOI: 10.1136/gut.2006.112169] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
81 Kim MY, Baik SK, Won CS, Park HJ, Jeon HK, Hong HI, Kim JW, Kim HS, Kwon SO, Kim JY, Yoo BS, Lee SH. Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis. Korean J Hepatol 2010;16:376-82. [PMID: 21415581 DOI: 10.3350/kjhep.2010.16.4.376] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
82 Ford RM, Sakaria SS, Subramanian RM. Critical care management of patients before liver transplantation. Transplant Rev (Orlando) 2010;24:190-206. [PMID: 20688502 DOI: 10.1016/j.trre.2010.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
83 Ripoll C, Yotti R, Bermejo J, Bañares R. The heart in liver transplantation. J Hepatol 2011;54:810-22. [PMID: 21145840 DOI: 10.1016/j.jhep.2010.11.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 42] [Article Influence: 4.9] [Reference Citation Analysis]
84 Pimentel CFMG, Amaral ACC, Gonzalez AM, Lai M, Mota DO, Ferraz MLG, Junior WM, Kondo M. Six-minute walking test performance is associated with survival in cirrhotic patients. World J Hepatol 2021; 13(11): 1791-1801 [PMID: 34904046 DOI: 10.4254/wjh.v13.i11.1791] [Reference Citation Analysis]
85 Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int 2018;38:570-80. [PMID: 28921803 DOI: 10.1111/liv.13589] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 14.3] [Reference Citation Analysis]
86 Josefsson A, Fu M, Björnsson E, Castedal M, Kalaitzakis E. Pre-transplant renal impairment predicts posttransplant cardiac events in patients with liver cirrhosis. Transplantation 2014;98:107-14. [PMID: 24621533 DOI: 10.1097/01.TP.0000442781.31885.a2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
87 Findlay JY, Wen D, Mandell MS. Cardiac risk evaluation for abdominal transplantation: . Current Opinion in Organ Transplantation 2010;15:363-7. [DOI: 10.1097/mot.0b013e328338a986] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
88 Bernardi M. Cirrhotic cardiomyopathy. Clin Liver Dis (Hoboken) 2013;2:99-101. [PMID: 30992835 DOI: 10.1002/cld.141] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
89 Wiese S, Hove JD, Møller S. Cardiac imaging in patients with chronic liver disease. Clin Physiol Funct Imaging. 2015; Nov 5. [Epub ahead of print]. [PMID: 26541640 DOI: 10.1111/cpf.12311] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
90 Koshy AN, Farouque O, Cailes B, Testro A, Ramchand J, Sajeev JK, Han HC, Srivastava PM, Jones EF, Salehi H, Teh AW, Lim HS, Calafiore P, Gow PJ. Impaired Cardiac Reserve on Dobutamine Stress Echocardiography Predicts the Development of Hepatorenal Syndrome. Am J Gastroenterol 2020;115:388-97. [PMID: 31738284 DOI: 10.14309/ajg.0000000000000462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
91 Park J, Lee J, Kwon A, Choi HJ, Chung HS, Hong SH, Park CS, Choi JH, Chae MS. The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation. PLoS One 2019;14:e0215603. [PMID: 31013321 DOI: 10.1371/journal.pone.0215603] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
92 Rössle M. TIPS: 25years later. Journal of Hepatology 2013;59:1081-93. [DOI: 10.1016/j.jhep.2013.06.014] [Cited by in Crossref: 184] [Cited by in F6Publishing: 150] [Article Influence: 20.4] [Reference Citation Analysis]
93 Wiese S, Hove JD, Mo S, Mygind ND, Tønnesen J, Petersen CL, Clemmesen JO, Goetze JP, Bendtsen F, Møller S. Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imaging. Am J Physiol Gastrointest Liver Physiol 2019;317:G253-63. [PMID: 31216181 DOI: 10.1152/ajpgi.00402.2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
94 Willmann S, Coboeken K, Kapsa S, Thelen K, Mundhenke M, Fischer K, Hügl B, Mück W. Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban-Renal and Hepatic Impairment and Drug-Drug Interaction Potential. J Clin Pharmacol 2021;61:656-65. [PMID: 33205449 DOI: 10.1002/jcph.1784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Persaud A, Ahmed A, Kakked G, Shulik O, Ahlawat S. Association of Autoimmune Hepatitis and Cardiovascular Disease. Digestive and Liver Disease 2019;51:1604-9. [DOI: 10.1016/j.dld.2019.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
96 Farouk H, Al-maimoony T, Nasr A, El-serafy M, Ghany MA. Echocardiographic assessment of the left ventricular diastolic function in patients with non-alcoholic liver cirrhosis. Cor Vasa 2017;59:e540-5. [DOI: 10.1016/j.crvasa.2016.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
97 Johnson TN, Boussery K, Rowland-Yeo K, Tucker GT, Rostami-Hodjegan A. A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance. Clin Pharmacokinet. 2010;49:189-206. [PMID: 20170207 DOI: 10.2165/11318160-000000000-00000] [Cited by in Crossref: 124] [Cited by in F6Publishing: 110] [Article Influence: 10.3] [Reference Citation Analysis]
98 Malik MU, Russell SD, Pustavoitau A, Chacko M, Cosar AM, Thompson CB, Trilianos P, Dagher NN, Cameron AM, Gurakar A. The predictors of post-transplant coronary events among liver transplant recipients. Hepatol Int. 2016;10:974-982. [PMID: 27311889 DOI: 10.1007/s12072-016-9742-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
99 Al-Khafaji A, Huang DT. Critical care management of patients with end-stage liver disease. Crit Care Med 2011;39:1157-66. [PMID: 21336121 DOI: 10.1097/CCM.0b013e318211fdc4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
100 Carvalho MVH, Kroll PC, Kroll RTM, Carvalho VN. Cirrhotic cardiomyopathy: the liver affects the heart. Braz J Med Biol Res 2019;52:e7809. [PMID: 30785477 DOI: 10.1590/1414-431X20187809] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
101 Dourakis SP, Geladari E, Geladari C, Vallianou N. Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased? Curr Cardiol Rev 2021;17:78-84. [PMID: 31072296 DOI: 10.2174/1573403X15666190509084519] [Reference Citation Analysis]
102 Nazar A, Guevara M, Sitges M, Terra C, Solà E, Guigou C, Arroyo V, Ginès P. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol. 2013;58:51-57. [PMID: 22989573 DOI: 10.1016/j.jhep.2012.08.027] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 8.6] [Reference Citation Analysis]
103 Nelson JA, Mortensen MJ, Horslen S, Bhat AH. Impact of nutritional status on prevalence of left ventricular hypertrophy in children undergoing liver transplant. Pediatr Transplant 2021;25:e14011. [PMID: 34004058 DOI: 10.1111/petr.14011] [Reference Citation Analysis]
104 Biomy R, Abdelshafy M, Abdelmonem A, Abu-Elenin H, Ghaly G. Effect of Chronic Hepatitis C Virus Treatment by Combination Therapy on Cardiovascular System. Clin Med Insights Cardiol 2017;11:1179546817713204. [PMID: 28804248 DOI: 10.1177/1179546817713204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
105 Kim YK, Shin WJ, Song JG, Kim Y, Kim WJ, Kim SH, Hwang GS. Evaluation of intraoperative brain natriuretic peptide as a predictor of 1-year mortality after liver transplantation. Transplant Proc 2011;43:1684-90. [PMID: 21693258 DOI: 10.1016/j.transproceed.2011.02.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
106 Behera MK, Swain SN, Sahu MK, Behera GK, Mishra D, Narayan J, Singh A, Agarwal S, Mallick PK. Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis. Int J Hepatol 2021;2021:5592376. [PMID: 34900353 DOI: 10.1155/2021/5592376] [Reference Citation Analysis]
107 Rössle M, Schupp JC, Köhler TC, Schultheiss M. Editorial: cardiac volume overload and pulmonary hypertension in long-term follow-up of TIPSS patients. Aliment Pharmacol Ther 2016;43:1233-5. [DOI: 10.1111/apt.13599] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
108 Umgelter A, Reindl W, Geisler F, Saugel B, Huber W, Berger H, Schmid RM. Effects of TIPS on global end-diastolic volume and cardiac output and renal resistive index in ICU patients with advanced alcoholic cirrhosis. Annals of Hepatology 2010;9:40-5. [DOI: 10.1016/s1665-2681(19)31677-1] [Cited by in Crossref: 13] [Article Influence: 1.1] [Reference Citation Analysis]
109 Mani AR, Ippolito S, Ollosson R, Moore KP. Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis. Hepatology. 2006;43:847-856. [PMID: 16557556 DOI: 10.1002/hep.21115] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
110 Babaei-Karamshahlou M, Hooshmand B, Hajizadeh S, Mani AR. The role of endogenous hydrogen sulfide in pathogenesis of chronotropic dysfunction in rats with cirrhosis. Eur J Pharmacol 2012;696:130-5. [PMID: 23043860 DOI: 10.1016/j.ejphar.2012.09.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
111 Bay Nielsen H, Secher NH, Clemmesen O, Ott P. Maintained cerebral and skeletal muscle oxygenation during maximal exercise in patients with liver cirrhosis. Journal of Hepatology 2005;43:266-71. [DOI: 10.1016/j.jhep.2005.02.039] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
112 Møller S, Henriksen JH. Cirrhotic cardiomyopathy. Journal of Hepatology 2010;53:179-90. [DOI: 10.1016/j.jhep.2010.02.023] [Cited by in Crossref: 209] [Cited by in F6Publishing: 174] [Article Influence: 17.4] [Reference Citation Analysis]
113 Rai R, Nagral S, Nagral A. Surgery in a patient with liver disease. J Clin Exp Hepatol. 2012;2:238-246. [PMID: 25755440 DOI: 10.1016/j.jceh.2012.05.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
114 Torregrosa M, Aguadé S, Dos L, Segura R, Gónzalez A, Evangelista A, Castell J, Margarit C, Esteban R, Guardia J. Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol. 2005;42:68-74. [PMID: 15629509 DOI: 10.1016/j.jhep.2004.09.008] [Cited by in Crossref: 213] [Cited by in F6Publishing: 166] [Article Influence: 12.5] [Reference Citation Analysis]
115 Krag A, Bendtsen F, Mortensen C, Henriksen JH, Møller S. Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis. Eur J Gastroenterol Hepatol. 2010;22:1085-1092. [PMID: 20453655 DOI: 10.1097/meg.0b013e32833a4822] [Cited by in Crossref: 46] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
116 Muilenburg DJ, Singh A, Torzilli G, Khatri VP. Surgery in the patient with liver disease. Anesthesiol Clin 2009;27:721-37. [PMID: 19942176 DOI: 10.1016/j.anclin.2009.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
117 Møller S, Dümcke CW, Krag A. The heart and the liver. Expert Rev Gastroenterol Hepatol. 2009;3:51-64. [PMID: 19210113 DOI: 10.1586/17474124.3.1.51] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
118 Bellar A, Welch N, Dasarathy S. Exercise and physical activity in cirrhosis: opportunities or perils. J Appl Physiol (1985) 2020;128:1547-67. [PMID: 32240017 DOI: 10.1152/japplphysiol.00798.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
119 Møller S, Wiese S, Halgreen H, Hove JD. Diastolic dysfunction in cirrhosis. Heart Fail Rev 2016;21:599-610. [DOI: 10.1007/s10741-016-9552-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
120 Lemyze M, Dharancy S, Wallaert B. Response to exercise in patients with liver cirrhosis: implications for liver transplantation. Dig Liver Dis. 2013;45:362-366. [PMID: 23137795 DOI: 10.1016/j.dld.2012.09.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
121 Møller S, Danielsen KV, Wiese S, Hove JD, Bendtsen F. An update on cirrhotic cardiomyopathy. Expert Rev Gastroenterol Hepatol 2019;13:497-505. [PMID: 30802157 DOI: 10.1080/17474124.2019.1587293] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
122 Sampaio F, Pimenta J. Left ventricular function assessment in cirrhosis: Current methods and future directions. World J Gastroenterol 2016; 22(1): 112-125 [PMID: 26755864 DOI: 10.3748/wjg.v22.i1.112] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
123 Trájer E, Bosnyák E, Komka Z, Kováts T, Protzner A, Szmodis M, Tóth S, Udvardy A, Tóth M. Retrospective Study of the Hungarian National Transplant Team's Cardiorespiratory Capacity. Transplantation Proceedings 2015;47:1600-4. [DOI: 10.1016/j.transproceed.2015.02.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
124 Guèye MN, Louise BM, Malick B, Salamata D, Aïssé TM, Ambdil H, Polèle FM, Bamba CCA, Daouda D, Mouhamadou M, Abdou BS, Lamine DM. [Electrocardiographic and echocardiographic abnormalities in patients with cirrhosis due to viral hepatitis B: about 60 cases reported in the Hepatogastroenterologic Department at the Aristide Le Dantec Hospital in Dakar (HALD)]. Pan Afr Med J 2018;30:169. [PMID: 30455798 DOI: 10.11604/pamj.2018.30.169.12344] [Reference Citation Analysis]
125 Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet J Rare Dis. 2007;2:15. [PMID: 17389039 DOI: 10.1186/1750-1172-2-15] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
126 Merli M, Lucidi C, Di Gregorio V, Giannelli V, Giusto M, Ceccarelli G, Riggio O, Venditti M. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int. 2015;35:362-369. [PMID: 24836902 DOI: 10.1111/liv.12593] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
127 Busk TM, Bendtsen F, Møller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol. 2013;25:523-530. [PMID: 23325273 DOI: 10.1097/MEG.0b013e32835d09fe] [Cited by in Crossref: 22] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
128 Hulo S, Edme JL, Inamo J, Van Bulck R, Dharancy S, Neviere R. Elevated alveolar nitric oxide is linked to poor aerobic capacity and chronotropic incompetence in liver transplant candidates. J Breath Res 2018;12:046008. [PMID: 30080156 DOI: 10.1088/1752-7163/aad847] [Reference Citation Analysis]
129 Wiese S, Hove JD, Bendtsen F, Møller S. Cirrhotic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2014;11:177-186. [PMID: 24217347 DOI: 10.1038/nrgastro.2013.210] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 14.0] [Reference Citation Analysis]
130 Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: review of pathophysiology and treatment. Hepatol Int. 2014;8:308-315. [PMID: 25221635 DOI: 10.1007/s12072-014-9531] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Barakat AA, Nasr FM, Metwaly AA, El-Ghannam M. Systemic vascular resistance and fluid status in patients with decompensated liver cirrhosis with or without functional renal failure in Egypt. Electron Physician 2015;7:1174-82. [PMID: 26396731 DOI: 10.14661/2015.1174-1182] [Reference Citation Analysis]
132 Seiberlich E, Sanches MD, Morais BS, Maciel JF. Influence of preoperative propranolol on cardiac index during the anhepatic phase of liver transplantation. Braz J Anesthesiol 2015;65:170-6. [PMID: 25925027 DOI: 10.1016/j.bjane.2014.02.017] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Desai MS, Shabier Z, Taylor M, Lam F, Thevananther S, Kosters A, Karpen SJ. Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis. Hepatology. 2010;51:2097-2107. [PMID: 20512997 DOI: 10.1002/hep.23585] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
134 Salari A, Shafaghi A, Ofoghi M, Saeidinia A, Mansour-Ghanaei F. Diastolic dysfunction and severity of cirrhosis in nonalcoholic cirrhotic patients. Int J Hepatol 2013;2013:892876. [PMID: 24377048 DOI: 10.1155/2013/892876] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
135 Yoon KT, Liu H, Lee SS. Cirrhotic Cardiomyopathy. Curr Gastroenterol Rep 2020;22:45. [PMID: 32651721 DOI: 10.1007/s11894-020-00783-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
136 Tsai MH. Splanchnic and systemic vasodilatation: the patient. J Clin Gastroenterol 2007;41 Suppl 3:S266-71. [PMID: 17975476 DOI: 10.1097/MCG.0b013e3181576d1a] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
137 Li YJ, Lei X, Yin H, Bai XL, Yan WT, Yang GM, Gui LL, Tan HB. Cirrhotic cardiomyopathy: Basic and clinical research. Shijie Huaren Xiaohua Zazhi 2016; 24(27): 3846-3852 [DOI: 10.11569/wcjd.v24.i27.3846] [Reference Citation Analysis]
138 Aby ES, Saab S. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients. Clinics in Liver Disease 2019;23:589-605. [DOI: 10.1016/j.cld.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
139 Mancuzo EV, Pereira RM, Sanches MD, Mancuzo AV. Pre-Transplant Aerobic Capacity and Prolonged Hospitalization After Liver Transplantation. GE Port J Gastroenterol 2015;22:87-92. [PMID: 28868384 DOI: 10.1016/j.jpge.2015.02.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
140 Sharma A, Fletcher A, Lipscomb GR. Pulmonary oedema after therapeutic ascitic paracentesis: a case report and literature review of the cardiac complications of cirrhosis. Eur J Gastroenterol Hepatol 2010;22:241-5. [PMID: 19801941 DOI: 10.1097/MEG.0b013e32833110f7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
141 Desai MS, Zainuer S, Kennedy C, Kearney D, Goss J, Karpen SJ. Cardiac structural and functional alterations in infants and children with biliary atresia, listed for liver transplantation. Gastroenterology 2011;141:1264-72, 1272.e1-4. [PMID: 21762660 DOI: 10.1053/j.gastro.2011.06.082] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
142 Pellicori P, Torromeo C, Calicchia A, Ruffa A, Di Iorio M, Cleland JG, Merli M. Does cirrhotic cardiomyopathy exist? 50 years of uncertainty. Clin Res Cardiol. 2013;102:859-864. [PMID: 23995321 DOI: 10.1007/s00392-013-0610-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
143 Martinez-palli G, Cárdenas A. Pre operative cardio pulmonary assessment of the liver transplant candidate. Annals of Hepatology 2011;10:421-33. [DOI: 10.1016/s1665-2681(19)31508-x] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
144 Figueiredo A, Romero-Bermejo F, Perdigoto R, Marcelino P. The end-organ impairment in liver cirrhosis: appointments for critical care. Crit Care Res Pract. 2012;2012:539412. [PMID: 22666568 DOI: 10.1155/2012/539412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
145 Merli M, Calicchia A, Ruffa A, Pellicori P, Riggio O, Giusto M, Gaudio C, Torromeo C. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med. 2013;24:172-176. [PMID: 22958907 DOI: 10.1016/j.ejim.2012.08.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
146 Tzamouranis DG, Alexopoulou A, Dourakis SP, Stergiou GS. Relationship of 24-hour ambulatory blood pressure and heart rate with markers of hepatic function in cirrhotic patients. BMC Gastroenterol 2010;10:143. [PMID: 21143998 DOI: 10.1186/1471-230X-10-143] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
147 Wehmeyer MH, Heuer AJ, Benten D, Püschel K, Sydow K, Lohse AW, Lüth S. High Rate of Cardiac Abnormalities in a Postmortem Analysis of Patients Suffering From Liver Cirrhosis. J Clin Gastroenterol 2015;49:866-72. [PMID: 25856382 DOI: 10.1097/MCG.0000000000000323] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
148 Benjaminov FS, Prentice M, Sniderman KW, Siu S, Liu P, Wong F. Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut. 2003;52:1355-1362. [PMID: 12912870 DOI: 10.1136/gut.52.9.1355] [Cited by in Crossref: 120] [Cited by in F6Publishing: 81] [Article Influence: 6.3] [Reference Citation Analysis]
149 Khan RS, Newsome PN. Non-alcoholic fatty liver disease and liver transplantation. Metabolism. 2016;65:1208-1223. [PMID: 26997540 DOI: 10.1016/j.metabol.2016.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
150 Naqvi IH, Mahmood K, Naeem M, Vashwani AS, Ziaullah S. The heart matters when the liver shatters! Cirrhotic cardiomyopathy: frequency, comparison, and correlation with severity of disease. Prz Gastroenterol 2016;11:247-56. [PMID: 28053679 DOI: 10.5114/pg.2016.57962] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
151 El-sayed MS, Ali N, El-sayed Ali Z. Interaction Between Alcohol and Exercise: Physiological and Haematological Implications. Sports Medicine 2005;35:257-69. [DOI: 10.2165/00007256-200535030-00005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
152 Wong F. The use of TIPS in chronic liver disease. Annals of Hepatology 2006;5:5-15. [DOI: 10.1016/s1665-2681(19)32033-2] [Cited by in Crossref: 29] [Article Influence: 1.8] [Reference Citation Analysis]